[
  {
    "ts": null,
    "headline": "Edwards Lifesciences (EW): Revisiting Valuation and Growth Potential After Recent Share Price Swings",
    "summary": "Edwards Lifesciences (EW) shares have experienced movement recently, drawing interest from investors tracking shifts in the medical device sector. The company’s recent performance presents a useful opportunity to revisit its fundamentals, market position, and potential outlook. See our latest analysis for Edwards Lifesciences. After some recent ups and downs, Edwards Lifesciences’ share price has advanced 4.84% year-to-date. The one-year total shareholder return is 9.69%. While short-term...",
    "url": "https://finnhub.io/api/news?id=4e7220716c12e9138257df5684c293bc49843fe8df20651b2deeaeed335375df",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761343882,
      "headline": "Edwards Lifesciences (EW): Revisiting Valuation and Growth Potential After Recent Share Price Swings",
      "id": 137217525,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (EW) shares have experienced movement recently, drawing interest from investors tracking shifts in the medical device sector. The company’s recent performance presents a useful opportunity to revisit its fundamentals, market position, and potential outlook. See our latest analysis for Edwards Lifesciences. After some recent ups and downs, Edwards Lifesciences’ share price has advanced 4.84% year-to-date. The one-year total shareholder return is 9.69%. While short-term...",
      "url": "https://finnhub.io/api/news?id=4e7220716c12e9138257df5684c293bc49843fe8df20651b2deeaeed335375df"
    }
  },
  {
    "ts": null,
    "headline": "Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?",
    "summary": "Stryker's Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics, partly offset by tariff headwinds.",
    "url": "https://finnhub.io/api/news?id=0c1e508349d242f8bcc2ca1af84a11338ddc5e554d82e1eebef35c5efa36bdcc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761310800,
      "headline": "Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?",
      "id": 137216576,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Stryker's Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics, partly offset by tariff headwinds.",
      "url": "https://finnhub.io/api/news?id=0c1e508349d242f8bcc2ca1af84a11338ddc5e554d82e1eebef35c5efa36bdcc"
    }
  }
]